• Tuesday, Nov 30, 2021
  • Last Update : 06:31 pm

AstraZeneca claims their Covid-19 vaccine has winning formula

  • Published at 11:30 am December 28th, 2020
AstraZeneca
File photo: AstraZeneca's logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020 Reuters

He believes trials will show his firm has achieved a vaccine efficacy equal to Pfizer-BioNTech and Moderna

The Covid-19 vaccine developed by the British drugs group AstraZeneca and the University of Oxford has achieved a "winning formula" for efficacy, the company's chief executive said on Sunday.

The vaccine, currently being evaluated by Britain's independent medicines regulator, provides "100% protection" against severe Covid disease requiring hospitalization, Pascal Soriot said in an interview with the Sunday Times newspaper.

He added he believes trials will show his firm has achieved a vaccine efficacy equal to Pfizer-BioNTech at 95% and Moderna at 94.5%.

“We think we have figured out the winning formula and how to get efficacy that, after two doses, is up there with everybody else," the chief executive said, while saying only that data would be published at "some point".

The UK government announced on December 23 that the developers of the Oxford-AstraZeneca vaccine had submitted their data to the Medicines and Healthcare products Regulatory Agency (MHRA).

Approval is expected to be granted to roll out the jab on January 4, The Sunday Telegraph newspaper reported.

The Pfizer-BioNTech vaccine was the first coronavirus shot to be authorized for use by the UK's independent medicines regulator and has been given to 600,000 of the country's most vulnerable people since last month. 

Earlier trials had shown varying outcomes in the AstraZeneca shot's efficacy. The vaccine initially showed an average 70% effectiveness but that level jumped to 90% depending on dosage.


Also read: UK to roll out Oxford Covid-19 vaccine from Jan 4


Storm over data

Behind this average figure from large-scale trials in the UK and Brazil was a 62% effectiveness for those who were vaccinated with two full doses of the shot.

For volunteers who received a half-dose first and then a full dose one month later, however, the vaccine was found to have 90% efficacy.

Soriot said he was "surprised" by the initial findings. "We would have preferred a simpler set of results," he added.

The lack of clarity and transparency over the discrepancy in the results was widely criticized. Soriot said he had not expected the pushback that followed.

"We assumed people would be a bit disappointed, that’s for sure," he said. "But we didn’t expect that storm."

Great hopes have been placed on the AstraZeneca shot, originally based on a weakened version of a chimpanzee virus, because of its low cost.

AstraZeneca's vaccine also enjoys a logistical advantage over the Pfizer-BioNTech alternative, as it can be stored, transported and handled at normal refrigerated conditions of between 2°C and 8°C (36-46 Fahrenheit) for at least six months.

That is a far cry from the -70°C needed for Pfizer/BioNTech's offering and could allow use of the existing refrigerated supply chain to cut costs.

File photo: An illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes, with the logo of the University of Oxford and its partner British pharmaceutical company AstraZeneca on November 17, 2020.<strong>AFP</strong>

Light at the end of the tunnel

In a vote of confidence for its homegrown vaccine, the bulk of Britain's requirements are expected to be met by the jab.

The government has ordered 100 million doses, with 40 million doses scheduled to be available by the end of March.

UK officials will hope that confidence is rewarded, not least because the country has been one of the countries most affected by the pandemic with more than 70,000 deaths.

A surge in cases has hit nationwide over the past week, falling especially on the southeast of England and blamed on a new strain of the virus believed to be more infectious, which was first identified in the UK.

According to one British study the strain is 50% to 74% more contagious.

In an effort to contain the spread of the disease, millions across Britain were placed under tougher lockdown restrictions that came into force on December 26.

Dozens of countries have also imposed travel restrictions on the UK to stop the spread of the new strain.

Writing in the Mail on Sunday newspaper, Finance Minister Rishi Sunak acknowledged it had been "a tough year for everyone in this country". 

However, he added that "the early roll-out of vaccines – and the incredible work of our scientists and NHS – means we can now see light at the end of the tunnel".

Nearly 200 million doses of the AstraZeneca vaccine will be made before the end of the year, the UK drug manufacturer has said, and more than 700 million globally by the end of March 2021.

56
Facebook 53
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail